Pim1 promotes IFN-β production by interacting with IRF3
www.nature.com/emm
ARTICLE
OPEN
Pim1 promotes IFN-β production by interacting with IRF3
Ryeojin Ko1,2, Jeongin Seo1, Hana Park1, Nawon Lee1 and Soo Young Lee
1,2 ✉
1234567890();,:
© The Author(s) 2022
The Pim (proviral integration site for Moloney murine leukemia virus) proteins compose a serine threonine kinase family whose
members regulate cell proliferation, migration and cell survival. However, whether Pim kinases participate in innate immune
responses is unclear. Here, we show for the first time that Pim1 plays an essential role in the production of interferon (IFN)-β by
macrophages after their Toll-like receptor (TLR) pathway is activated by pathogen-associated molecular patterns (PAMPs).
Specifically, Pim1 was quickly upregulated in an NF-κB-dependent manner after TLR stimulation with PAMPs. Pim1 deficiency
reduced TLR3- or TLR4-stimulated IFN-β and IFN-stimulated gene (ISG) expression but not proinflammatory cytokine expression in
macrophages. Mechanistically, Pim1 specifically upregulates IRF3 phosphorylation and nuclear translocation. However, this role is
not dependent on Pim1 kinase activity. Rather, Pim1 appears to promote IRF3 phosphorylation by enhancing the formation of IFN-β
signaling complexes composed of TRIF, TRAF3, TBK1, and IRF3. Poly (I:C)-treated Pim1−/− mice produced less serum IFN-β and were
less likely to survive than wild-type mice. These findings show for the first time that Pim1 participates in TLR-mediated IFN-β
production, thus revealing a novel target for controlling antiviral innate immune responses.
Experimental & Molecular Medicine (2022) 54:2092–2103; https://doi.org/10.1038/s12276-022-00893-y
INTRODUCTION
Innate immune cells form the first line of host defense against
pathogens because they express molecules called pattern
recognition receptors (PRRs) on their surface or endosomes. PPRs
recognize viral or bacterial molecules called pathogen-associated
molecular patterns (PAMPs). Upon binding of PAMPs, PRRs
activate multiple signaling cascades that cause innate immune
cells to produce inflammatory cytokines1–3 and two key subtypes
of the type I interferon (IFN) family, namely, IFN-α and IFN-β; the
latter is a highly conserved cytokine that plays critical roles in
antiviral innate immune responses4,5. Classical examples of PRRPAMP interactions involve Toll-like receptor 3 (TLR3) and TLR4,
which are highly conserved PRRs that recognize double-stranded
RNA (dsRNA) and lipopolysaccharide (LPS), respectively6,7. These
PRR-PAMP interactions induce the selective recruitment of an
immune adaptor protein known as toll-interleukin 1 (IL-1) receptor
homology (TIR) domain-containing adaptor inducing IFN-β (TRIF),
which binds to the TLR and then recruits downstream signaling
molecules that ultimately induce the production of IFN-β8–10.
Specifically, TRIF forms a signaling complex with TNF receptorassociated factor (TRAF) that activates tank-binding kinase 1
(TBK1)11,12, which in turn phosphorylates the master transcription
factor called interferon regulatory factor 3 (IRF3)13,14. This
phosphorylation event causes IRF3 to dimerize, translocate into
the nucleus, and induce the expression of IFN-β. IFN-β then
induces the expression of IFN-stimulated genes (ISGs) through the
Janus kinase (JAK)-signal transducer and activator of transcription
(STAT) pathway15,16.
Pim is a highly conserved serine/threonine kinase with three
isoforms, namely, Pim117–19, Pim220 and Pim321. The Pim1 gene
contains the upstream CUG start codon, and its Pim1L and Pim1S
isoforms are produced by alternative translation18. Pim kinases,
which have extensive amino acid homology, are constitutively
active and play critical roles in multiple cellular functions22,23,
including cell cycle control24, growth25, proliferation26, migration27, apoptosis28,29 and survival30. Indeed, numerous studies
have shown that all Pim kinases are oncogenic proteins that
promote tumorigenesis via diverse signaling pathways31–33. Pim
kinases also participate in adaptive immune responses, again via
disparate mechanisms34. For example, Pim1 promotes lymphocyte
proliferation and survival by suppressing apoptosis35 and promoting NFATc1 activity36. Moreover, it enhances CD8 + T-cell survival,
promotes
CD8 + T-cell
memory,
and
fosters
B-cell
proliferation37–39.
While Pim2 also promotes B-cell survival, it inhibits T-cell
immune responses; this is achieved by downregulating T-cell
production of pro-inflammatory cytokines40. In contrast, while
Pim3 also inhibits T-cell responses, it accomplishes this by
inhibiting CD4 + and CD8 + T-cell proliferation and activation41.
In addition, while all Pim kinases are expressed in both Th1 and
Th2 cells, their expression is higher in Th1 cells, and they promote
Th1-cell differentiation from precursor Th cells42.
In contrast, very little is known about the potential role of the
Pim kinase family in innate immune responses. Some very limited
recent evidence suggests that these kinases can also participate in
this arm of the immune system, especially during viral infection. In
particular, the results of two studies suggest that Pim1 may be
able to modulate virus-induced type I IFN signaling, which is an
important mediator of innate immunity43,44. Here, we expand this
finding by conducting exploratory analyses with Pim1-knockout
mice and RNA-seq analyses. We show for the first time that Pim1
facilitates the innate immune responses that are driven by TLR-
1
Department of Life Science, Ewha Womans University, Seoul, Korea. 2The Research Center for Cellular Homeostasis, Ewha Womans University, Seoul, Korea.
✉email:
Received: 15 April 2022 Revised: 26 September 2022 Accepted: 3 October 2022
Published online: 29 November 2022
R. Ko et al.
2093
mediated IFN-β production. Specifically, we observed that Pim1
expression was elevated soon after TLR stimulation and that Pim1
deficiency significantly reduced the phosphorylation and nuclear
translocation of IRF3. Our other findings suggest that Pim1
promotes IFN-β expression by enhancing the formation of a cell
surface signaling complex composed of TRIF, TRAF3, TBK1, and
IRF3; this complex then induces IRF3 phosphorylation. Importantly, the kinase activity of Pim1 was not needed for this function.
Our findings thus show that Pim1 can positively regulate the TLR
signaling pathway. These observations may provide insights into
potential approaches to controlling antiviral responses.
MATERIALS AND METHODS
Mice
Pim1−/− mice were generated by Macrogen via CRISPR/Cas9-mediated
genome editing. All mice were on the C57BL/6 genetic background and
were bred in the animal facility under specific-pathogen-free conditions.
All animal experimental procedures were approved by the Institutional
Animal Care and Use Committee (IACUC) of Ewha Womans University (No.
19-006).
Cells
Murine BMDMs were generated by flushing bone marrow cells from the
femurs and tibias of 8- to 10-week-old male C57BL/6 mice, suspending
them in Dulbecco’s modified Eagle’s medium (DME (...truncated)